POST Online Media Lite Edition


Pfizer: Anthony J. Coyle to head Global Centers for Therapeutic Innovation

Staff writer |
New York, USA - November 16, 2010, New York, USA - Pfizer Inc. announced the establishment of the Global Centers for Therapeutic Innovation and the appointment of Anthony J. Coyle as its head .

Article continues below

Dr. Coyle brings extensive knowledge of the full drug development process to this initiative. As vice president, research and development, and head, inflammation and autoimmunity research, Anthony J. Coyle, Ph.D., oversees MedImmune's preclinical research in disease areas such as asthma, lupus, rheumatoid arthritis and sepsis.

Prior to joining MedImmune as a senior director in 2005, Dr. Coyle served as director, inflammation biology, at Millennium Pharmaceuticals in Cambridge, Massachusetts. In addition, he worked as a research scientist in the immunology department at the Glaxo Institute for Molecular Biology in Geneva, Switzerland.

He also has more than six years of experience as a post-doctoral research assistant in immunology and pharmacology at Institut Pasteur in Paris and the National Jewish Center of Immunology in Denver.


Ichnos Sciences appoints Sonia Quaratino to board
Ichnos Sciences welcomes Eric Feldman as new chief medical officer
Capital One Financial appoints Christine Detrick to board
Bankers Insurance hires David A. Erwin as president and CEO
American Equity Investment Life Holding appoints Dewayne Lummus as SVP

What to read next

Director M. Anthony Burns steps down from Pfizer
Intrexon appoints Geno Germano as president
Pfizer: Jeffrey B. Kindler retires, Ian C. Read successor